Astellas Pharma Inc. - Laporan Laba Rugi (TTM)

Astellas Pharma Inc.
JP ˙ TSE ˙ JP3942400007
JP¥ 1,701.00 ↑22.50 (1.34%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Astellas Pharma Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,265,853 1,253,215 1,249,528 1,268,702 1,285,714 1,300,914 1,296,163 1,351,811 1,406,682 1,468,235 1,518,619 1,511,818 1,523,572 1,543,324 1,603,672 1,701,806 1,772,155 1,867,631 1,912,323 1,944,993
Change (%) -1.00 -0.29 1.53 1.34 1.18 -0.37 4.29 4.06 4.38 3.43 -0.45 0.78 1.30 3.91 6.12 4.13 5.39 2.39 1.71
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 257,416 242,833 246,063 248,640 251,250 252,421 253,009 279,648 279,924 284,988 288,353 268,430 280,061 281,536 292,485 314,674 322,951 345,577 349,206 352,899
Change (%) -5.67 1.33 1.05 1.05 0.47 0.23 10.53 0.10 1.81 1.18 -6.91 4.33 0.53 3.89 7.59 2.63 7.01 1.05 1.06
% of Revenue 20.34 19.38 19.69 19.60 19.54 19.40 19.52 20.69 19.90 19.41 18.99 17.76 18.38 18.24 18.24 18.49 18.22 18.50 18.26 18.14
Gross Operating Profit 1,008,437 1,010,382 1,003,465 1,020,062 1,034,464 1,048,493 1,043,154 1,072,163 1,126,758 1,183,247 1,230,266 1,243,388 1,243,511 1,261,788 1,311,187 1,387,132 1,449,204 1,522,054 1,563,117 1,592,094
Change (%) 0.19 -0.68 1.65 1.41 1.36 -0.51 2.78 5.09 5.01 3.97 1.07 0.01 1.47 3.91 5.79 4.47 5.03 2.70 1.85
% of Revenue 79.66 80.62 80.31 80.40 80.46 80.60 80.48 79.31 80.10 80.59 81.01 82.24 81.62 81.76 81.76 81.51 81.78 81.50 81.74 81.86
SG&A 515,363 508,764 504,316 520,649 532,687 547,692 548,840 565,127 586,290 613,397 630,272 645,058 669,778 706,256 736,496 775,191 799,059 821,251 843,032 833,152
Change (%) -1.28 -0.87 3.24 2.31 2.82 0.21 2.97 3.74 4.62 2.75 2.35 3.83 5.45 4.28 5.25 3.08 2.78 2.65 -1.17
% of Revenue 40.71 40.60 40.36 41.04 41.43 42.10 42.34 41.81 41.68 41.78 41.50 42.67 43.96 45.76 45.93 45.55 45.09 43.97 44.08 42.84
R&D 230,952 233,293 224,489 225,514 231,849 233,316 246,010 261,704 266,127 274,414 276,128 266,713 278,898 286,410 294,187 316,416 324,570 329,275 327,651 312,528
Change (%) 1.01 -3.77 0.46 2.81 0.63 5.44 6.38 1.69 3.11 0.62 -3.41 4.57 2.69 2.72 7.56 2.58 1.45 -0.49 -4.62
% of Revenue 18.24 18.62 17.97 17.78 18.03 17.93 18.98 19.36 18.92 18.69 18.18 17.64 18.31 18.56 18.34 18.59 18.31 17.63 17.13 16.07
OpEx 1,074,830 1,065,835 998,596 1,042,814 1,032,063 1,066,509 1,078,018 1,136,835 1,160,456 1,213,598 1,286,967 1,267,739 1,363,884 1,426,527 1,516,811 1,606,681 1,602,174 1,667,169 1,648,783 1,656,223
Change (%) -0.84 -6.31 4.43 -1.03 3.34 1.08 5.46 2.08 4.58 6.05 -1.49 7.58 4.59 6.33 5.92 -0.28 4.06 -1.10 0.45
% of Revenue 84.91 85.05 79.92 82.20 80.27 81.98 83.17 84.10 82.50 82.66 84.75 83.86 89.52 92.43 94.58 94.41 90.41 89.27 86.22 85.15
Operating Income 191,023 187,380 250,932 225,888 253,651 234,405 218,145 214,976 246,226 254,637 231,652 244,079 159,688 116,797 86,861 95,125 169,981 200,462 263,540 288,770
Change (%) -1.91 33.92 -9.98 12.29 -7.59 -6.94 -1.45 14.54 3.42 -9.03 5.36 -34.58 -26.86 -25.63 9.51 78.69 17.93 31.47 9.57
% of Revenue 15.09 14.95 20.08 17.80 19.73 18.02 16.83 15.90 17.50 17.34 15.25 16.14 10.48 7.57 5.42 5.59 9.59 10.73 13.78 14.85
Interest Expense -1,510 -1,674 -2,118 -2,879 -4,660 -8,084 -2,315 -2,994 -3,247 -4,748 -3,217 -3,541 -4,302 -4,329 -12,005 -13,780 -11,977 -17,956 -13,952 -19,080
Change (%) 10.86 26.52 35.93 61.86 73.48 -71.36 29.33 8.45 46.23 -32.25 10.07 21.49 0.63 177.32 14.79 -13.08 49.92 -22.30 36.75
% of Revenue -0.12 -0.13 -0.17 -0.23 -0.36 -0.62 -0.18 -0.22 -0.23 -0.32 -0.21 -0.23 -0.28 -0.28 -0.75 -0.81 -0.68 -0.96 -0.73 -0.98
Net Income 139,722 138,307 120,589 100,863 119,360 120,167 124,086 118,211 148,911 136,430 98,714 107,031 38,090 4,198 17,045 21,519 54,746 -57,427 50,747 81,566
Change (%) -1.01 -12.81 -16.36 18.34 0.68 3.26 -4.73 25.97 -8.38 -27.64 8.43 -64.41 -88.98 306.03 26.25 154.41 -204.90 -188.37 60.73
% of Revenue 11.04 11.04 9.65 7.95 9.28 9.24 9.57 8.74 10.59 9.29 6.50 7.08 2.50 0.27 1.06 1.26 3.09 -3.07 2.65 4.19

Source: Capital IQ

Other Listings
DE:YPH € 9.64
MX:4503 N
US:ALPMF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista